Serotype 3 Streptococcus pneumoniae Escapes the Immune Responses Induced by PCV13 in Mice With High Susceptibility to Infection

被引:0
|
作者
Oliveira, Giuliana S. [1 ]
Rivera, Johanna [2 ,3 ]
Rodrigues, Tasson C. [1 ]
Carneiro, Giovanna B. [1 ]
Ribeiro, Orlando G. [4 ]
Miyaji, Eliane N. [1 ]
Pirofski, Liise-anne [2 ,3 ]
Oliveira, Maria Leonor S. [1 ]
机构
[1] Inst Butantan, Bacteriol Lab, Sao Paulo, Brazil
[2] Albert Einstein Coll Med, Dept Med, Div Infect Dis, Bronx, NY USA
[3] Montefiore Med Ctr, Bronx, NY USA
[4] Inst Butantan, Immunogenet Lab, Sao Paulo, Brazil
关键词
COLONIZATION; PROTECTION; VIRULENCE; ANTIBODY;
D O I
10.1002/iid3.70062
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
BackgroundStreptococcus pneumoniae (pneumococcus) is a common cause of respiratory and invasive infections in humans. PCV13, a pneumococcal conjugate vaccine used globally, is highly effective against diseases caused by pneumococcal serotypes included in its formulation. However, one of them, the serotype 3 (ST3) is still being relatively commonly isolated from patients, suggesting an escape from vaccine-induced immunity. The thick capsule produced by ST3 facilitates bacterial evasion from the immune system. Additionally, host immune responses may influence the outcome of ST3 infection. Here we evaluated the influence of inflammation in the adaptive immune responses and protection induced by PCV13 against ST3, using two outbred mice lines that were phenotypically selected for high (AIRmax) and low (AIRmin) inflammatory responses.MethodsAIRmin and AIRmax mice were immunized with PCV13. Inbred BALB/c mice were used as reference for vaccine efficacy. Induction of IgG against polysaccharides (PS) from pneumococcal serotype 1 (ST1) and ST3 were evaluated by ELISA. Protection was tested against invasive infections with ST1 and ST3 pneumococcal strains. Sera were compared by IgG binding to pneumococcal surface, induction of pneumococcal agglutination and opsonophagocytosis. The phagocytic capacity of mice-derived neutrophils was also evaluated.ResultsImmunization of AIRmin, AIRmax and BALB/c mice with PCV13 induced IgG against PS from ST1 and ST3 pneumococci. Despite vaccination, AIRmin mice were not protected against fatal infection with ST3. Sera from AIRmin mice immunized with PCV13 presented lower levels of anti-PS3 IgG, with reduced capacity to bind to pneumococcal surface. Reduced capacity to induce opsonophagocytosis of ST3 pneumococci in vitro was also observed. Conversely, PCV13 protected AIRmin mice against fatal infection with ST1 and this correlated with the capacity of the sera to induce ST1 opsonophagocytosis.ConclusionsOur results show that both host and bacterial features can influence the outcome of protection induced by PCV13 against ST3 pneumococcal infection.
引用
收藏
页数:14
相关论文
共 36 条
  • [1] Necrotizing pneumonia caused by Streptococcus pneumoniae serotype 3 despite PCV13
    Alkan, Gulsum
    Emiroglu, Melike
    Dagi, Hatice T.
    Gurbuz, Venhar
    Ceyhan, Mehmet
    ARCHIVOS ARGENTINOS DE PEDIATRIA, 2019, 117 (02): : E155 - E157
  • [2] Antimicrobial susceptibility and serotype replacement of Streptococcus pneumoniae in children before and after PCV13 introduction in Taiwan
    Huang, Hsiang
    Lin, Chien-Yu
    Chiu, Nan-Chang
    Huang, Daniel Tsung-Ning
    Huang, Ching-Ying
    Chi, Hsin
    JOURNAL OF MICROBIOLOGY IMMUNOLOGY AND INFECTION, 2023, 56 (02) : 299 - 310
  • [3] Early Streptococcus pneumoniae serotype changes in Utah adults after the introduction of PCV13 in children
    Kendall, Brian A.
    Dascomb, Kristin K.
    Mehta, Rajesh R.
    Stockmann, Chris
    Mason, Edward O.
    Ampofo, Krow
    Pavia, Andrew T.
    Byington, Carrie L.
    VACCINE, 2016, 34 (04) : 474 - 478
  • [4] Increase in Streptococcus pneumoniae serotype 3 associated parapneumonic pleural effusion/empyema after the introduction of PCV13 in Germany
    Goettler, D.
    Streng, A.
    Kemmling, D.
    Schoen, C.
    von Kries, R.
    Rose, M. A.
    van der Linden, M.
    Liese, J. G.
    VACCINE, 2020, 38 (03) : 570 - 577
  • [5] Changes in the serotype distribution of Streptococcus pneumoniae causing otitis media after PCV13 introduction in Spain
    Morales, Maria
    Ludwig, Guillermo
    Ercibengoa, Maria
    Esteva, Cristina
    Sanchez-Encinales, Viviana L.
    Alonso, Marta
    Munoz-Almagro, Carmen
    Maria Marimon, Jose
    PLOS ONE, 2018, 13 (12):
  • [6] Genomic Characteristics of Invasive Streptococcus pneumoniae Serotype 1 in New Caledonia Prior to the Introduction of PCV13
    Hanachi, Mariem
    Kiran, Anmol
    Cornick, Jennifer
    Harigua-Souiai, Emna
    Everett, Dean
    Benkahla, Alia
    Souiai, Oussama
    BIOINFORMATICS AND BIOLOGY INSIGHTS, 2020, 14
  • [7] A systematic review about Streptococcus Pneumoniae serotype distribution in children in mainland of China before the PCV13 was licensed
    Lyu, Shuang
    Hu, Hui-li
    Yang, Yong-hong
    Yao, Kai-hu
    EXPERT REVIEW OF VACCINES, 2017, 16 (10) : 997 - 1006
  • [8] Streptococcus pneumoniae serotyping and antimicrobial susceptibility: assessment for vaccine efficacy in Canada after the introduction of PCV13
    Zhanel, George G.
    Lynch III, Joseph P.
    Adam, Heather J.
    JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2023, 78 : I2 - I7
  • [9] Streptococcus pneumoniae Serotype 3 in Mexico (1994 to 2017): Decrease of the Unusual Clonal Complex 4909 Lineage following PCV13 Introduction
    Echaniz-Aviles, Gabriela
    Guerreiro, Soraia, I
    Silva-Costa, Catarina
    Mendes, Catarina, I
    Carrico, Joao Andre
    Noemi Carnalla-Barajas, Maria
    Soto-Nogueron, Araceli
    Elena Velazquez-Meza, Maria
    Melo-Cristino, Jose
    Luevanos-Velazquez, Antonio
    Martinez-Medina, Lucia
    del Rosario Vazquez-Larios, Marfa
    Ramirez, Mario
    JOURNAL OF CLINICAL MICROBIOLOGY, 2019, 57 (01)
  • [10] Serotype Distribution and Antimicrobial Sensitivity Profile of Streptococcus pneumoniae Carried in Healthy Toddlers before PCV13 Introduction in Niamey, Niger
    Ousmane, Sani
    Diallo, Bouli A.
    Ouedraogo, Rasmata
    Sanda, Abdel-Kader A.
    Soussou, Amadou M.
    Collard, Jean-Marc
    PLOS ONE, 2017, 12 (01):